Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer

Drug resistance is always a great obstacle in any endocrine therapy of breast cancer. Although the combination of endocrine therapy and targeted therapy has been shown to significantly improve prognosis, refractory endocrine resistance is still common. Dysregulation of the Hippo pathway is often rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Wan, Runlan, Li, Qinqin, Rao, Zhenghuan, Wang, Yanlin, Zhang, Lei, Teichmann, Alexander Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194146/
https://www.ncbi.nlm.nih.gov/pubmed/34112175
http://dx.doi.org/10.1186/s12935-021-01999-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194146/
https://www.ncbi.nlm.nih.gov/pubmed/34112175
http://dx.doi.org/10.1186/s12935-021-01999-5

Ejemplares similares